MRI reveals Acupuncture's brain impact in migraine sufferers
NCT ID NCT04157192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how acupuncture affects the brain in people with migraine without aura. Forty adults received either real acupuncture or a sham (fake) version, and their brains were scanned with MRI before and after treatment. The goal was to see if real acupuncture causes different brain changes than the placebo, helping explain how it might reduce migraine attacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
May 2022
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients with two to eight bouts of migraine without an aura per month * All patient aged (≥) 18 to (≤) 60 years old * All patients who have not had a bout of migraine in the last 24 hours * All patients who have given free informed consent and have signed the consent form. * All patients who are affiliated to or beneficiaries of a health insurance scheme * All patients available for a two-month follow-up Exclusion Criteria: * All patients with migraine which is secondary to a neurological, neuropsychiatric, or vascular disorder * All patients suffering from diabetes * All patients with a past history of alcohol or drug abuse * All patients with contraindications for an MRI scan * All patients on antidepressants or Botox. * All patients already taking part in Category 1 research involving the human person * All patients on an exclusion period determined by another study * All patients placed under judicial protection, guardianship, or supervision * All patients for whom it is impossible to give the subject clear information * All patients who are pregnant, about to give birth or breastfeeding * All patient who have received botulinum toxin in the past year * All patient who have undergone antidepressant treatment in the last 2 months * All patient who have started a background migraine treatment for less than 3 months * All patient who have more than 14 migraine days per month
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acupuncture therapy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nîmes
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists aim to forecast migraine pain using wearable sensors and early symptoms
- New migraine sprays and tablets tested in ER for quick relief
- New digital program aims to ease migraine pain without drugs
- New migraine drug shows promise in Real-World study
- Heart procedure may offer lasting migraine relief, new study hopes to prove
- VR headsets take on migraine pain in new trial